Bellevue Asset Management ISIN LU1819585537

Bellevue Sustainable Healthcare

Bellevue Sustainable Healthcare is an active equity fund from Bellevue Asset Management, ISIN LU1819585537.

  • Active
  • Equity
  • Global
  • Fund size (GBP) £55.7M

The sub-fund is an equity fund. The investment objective of Bellevue Sustainable Healthcare is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare sector taking account of sustainability criteria. The fund can also invest in companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without limiting the scope of “healthcare sector”, the healthcare sector includes companies from the areas of pharmaceuticals, medical technology, biotechnology and related sectors. In particular, these are companies that create, develop, utilise, market and/or sell processes, methods, technologies, products or services which are used for diagnostic and therapeutic purposes in humans and animals, as well as companies whose activity mainly consists in holding shares in such companies or in financing such companies. The fund is managed taking sustainability criteria into consideration. This means that according to generally accepted approaches, environmental (ecological), social, societal, ethical and corporate governance criteria (ESG/CSR) are taken into account in the assessment and selection of a company for the portfolio. The selection of securities takes account of both exclusion criteria (negative selection) and the “best in class” method (positive selection) in selecting particularly sustainable companies in each sector. In addition, selection also takes account of impact criteria with regard to the United Nations’ Sustainable Development Goals (UN SDG). Exclusion criteria and best in class ESG/CSR criteria go by the following guidelines: • Austrian Environmental Authority guidelines • Guidelines for ethical sustainable investments in the Protestant Church • Orientation guidelines from the Catholic Church on “ethical sustainable investment” • Principles of the United Nations Global Compact These criteria relate, as far as is applicable, to companies in the healthcare sector, to the following issues, among others: • Environment: protecting natural resources, the atmosphere and inland waters; limiting land degradation and climate change; preventing interference in the ecosystem and loss of biodiversity • Social: mandatory non-discrimination; general human rights; prohibition of child and forced labour; product safety; health and safety in the workplace; fair working conditions and appropriate compensation • Corporate principles: anti-corruption principles in accordance with the UN Global Compac In addition, the Company may invest no more than one third of the net assets of Bellevue Sustainable Healthcare in carefully selected shares and other equity securities from other companies that have their registered office or carry out the majority of their economic activity in recognised countries, or in fixed-income or floating-rate securities, convertible bonds and bonds with warrants from issuers from recognised countries. Depending on market conditions, the Sub-fund may temporarily deviate from this equity ratio in so far as it is in the interests of investors, and invest in money market instruments with an investment grade rating at the time of purchase. Up to a maximum 15% of the net assets of Bellevue Sustainable Healthcare can be invested in warrants on shares or other securities. Purchases of warrants involve higher risks due to the increased volatility of these investments. Subject to being compliant with the limits and conditions defined by the CSSF, Bellevue Sustainable Healthcare may use derivative instruments in order to achieve an efficient portfolio management, in particular also for hedging purposes. The sub-fund may also invest up 10% of its net assets in units of UCITS and other UCIs. The sub-fund may invest up to 10% of its net assets in securities in accordance with Article 41 (2) (a) of the Law of 2010 and/or other unlisted securities in order to take advantage of investment opportunities in especially innovative projects in the healthcare sector. The company may in addition hold an adequate level of liquid assets for Bellevue Sustainable Healthcare. Bellevue Sustainable Healthcare is denominated in US dollars.

How the fund has returned, and where it ranks among peers. Returns to Sep 2026 end, GBP net total return.
+7.2% Q4
1 year return
+4.0% Q4
3 year return
−8.8% Q4
5 year return
Daily NAV, percent change from the start of the range. Source: FE fundinfo.
  • 1 month 0.0%
  • 3 months +1.1%
  • Volatility, 3 years 11.5%
  • Ongoing charge (OCF)
  • Fund size (GBP) £55.7M

What the fund holds

Where the money is: sectors, countries and largest holdings. As supplied by FE fundinfo, last updated 8 Oct 2026. Swipe or use the arrows for more panels.

By sector

Spot concentrations at a glance. Share of the fund's portfolio, as supplied by FE fundinfo, last updated 8 Oct 2026.
Biotechnology43.8%
Pharma39.0%
Services7.9%
See all sectorsA free account shows the full list.

By country

Spot concentrations at a glance. Share of the fund's portfolio, as supplied by FE fundinfo, last updated 8 Oct 2026.
United States65.3%
Switzerland13.1%
China6.0%
See all countriesA free account shows the full list.

By asset class

Spot concentrations at a glance. Share of the fund's portfolio, as supplied by FE fundinfo, last updated 8 Oct 2026.
US Equities65.3%
Swiss Equities13.1%
Chinese Equities6.0%
See all asset classesA free account shows the full list.

Largest holdings

The biggest positions, and how concentrated the fund is. As supplied by FE fundinfo, last updated 8 Oct 2026.
  1. 1. ELI LILLY AND COMPANY9.3%
  2. 2. MERCK & CO INC NEW7.3%
  3. 3. ABBVIE INC.5.9%
  4. 4. THERMO FISHER SCIENTIFIC INC.4.4%
  5. 5. AMGEN INC.4.3%
See all holdingsA free account shows the full list.

Macro events and this fund

Recent events linked to this fund by its country and sector exposure, and how it moved after. A measured move, not a cause.

Performance, risk and facts

Judge return, risk and cost before a client conversation. Relative return uses the chart's time range. Facts as reported by the manager.

Against its benchmark

How the fund compares with its benchmark over the same period.

Risk

How bumpy the ride has been, plus the regulatory risk rating.
Volatility, 3 years11.5%
Scale 0 to 40%
Sharpe ratio, 3 years (FE)0.00
Scale −1 to 3
Largest fall from a peak (maximum drawdown), 3 years
−16.0%

Volatility and maximum drawdown: calculated by Funds Benchmark, as at 30 Sep 2026.

Sharpe, alpha, beta: FE fundinfo, as at 7 Jul 2026.

Fund facts

Legal and cost facts for a client note. As reported by the manager.
ISIN
LU1819585537
Management company
Waystone Management Company (Lux) S.A.
Depositary
CACEIS Bank, Luxembourg Branch
Benchmark
MSCI World Healthcare Index
Ongoing charge
Share class launch date
29 Jun 2018
Domicile
LU
Fund type
open-ended fund
SRRI
4 of 7

What a sum would have become

What an amount would have grown to over the period.
n/a

Past performance is not a reliable guide to future returns. Capital is at risk. Source: FE fundinfo. Returns are GBP net total return to month end unless stated. Headline returns to Sep 2026. Fund size is shown in GBP.